These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27487996)

  • 1. NAT2 gene polymorphism: covert drug interaction causing phenytoin toxicity.
    Adithan C; Subathra A
    Indian J Med Res; 2016 May; 143(5):542-4. PubMed ID: 27487996
    [No Abstract]   [Full Text] [Related]  

  • 2. N-acetyltransferase 2 (NAT2) gene polymorphism as a predisposing factor for phenytoin intoxication in tuberculous meningitis or tuberculoma patients having seizures - A pilot study.
    Adole PS; Kharbanda PS; Sharma S
    Indian J Med Res; 2016 May; 143(5):581-90. PubMed ID: 27488001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyltransferase gene polymorphisms & plasma isoniazid concentrations in patients with tuberculosis.
    Hemanth Kumar AK; Ramesh K; Kannan T; Sudha V; Haribabu H; Lavanya J; Swaminathan S; Ramachandran G
    Indian J Med Res; 2017 Jan; 145(1):118-123. PubMed ID: 28574024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India.
    Gupta VH; Amarapurkar DN; Singh M; Sasi P; Joshi JM; Baijal R; Ramegowda PH; Amarapurkar AD; Joshi K; Wangikar PP
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1368-74. PubMed ID: 23875638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: a meta-analysis.
    Shi J; Xie M; Wang J; Xu Y; Liu X
    Pharmacogenomics; 2015 Dec; 16(18):2083-97. PubMed ID: 26616266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism of NAT2 metabolizing enzymes on phenytoin pharmacokinetics in Indian epileptic patients developing toxicity.
    Murali M; Manjari T; Madhuri B; Raghavan S; Jain DC; Vivekanandhan S
    CNS Neurosci Ther; 2012 Apr; 18(4):350-8. PubMed ID: 22268821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The association between NAT2 polymorphism and anti-tuberculosis drug-induced hepatitis].
    Wu YM; Luo ZY; Zhang HM; Peng JF; Liu SY; Wang M
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):467-9. PubMed ID: 20587321
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of isoniazid-metabolizing enzyme genotypes and isoniazid-induced hepatotoxicity in tuberculosis patients.
    Sotsuka T; Sasaki Y; Hirai S; Yamagishi F; Ueno K
    In Vivo; 2011; 25(5):803-12. PubMed ID: 21753138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylator status, drug metabolism and disease.
    Pande JN; Pande A; Singh SP
    Natl Med J India; 2003; 16(1):24-6. PubMed ID: 12715953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis.
    Huang YS; Chern HD; Su WJ; Wu JC; Lai SL; Yang SY; Chang FY; Lee SD
    Hepatology; 2002 Apr; 35(4):883-9. PubMed ID: 11915035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetyl transferase 2 polymorphisms associated with isoniazid pharmacodynamics: molecular features for ligand interaction.
    Ohkura K; Fukino K; Shinohara Y; Hori H
    Anticancer Res; 2010 Aug; 30(8):3177-80. PubMed ID: 20871037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of toxifying and detoxifying hepatic enzymes in amyotrophic lateral sclerosis.
    Bachus R; Neubert K; Roots I; Prudlo J; Brockmöller J; Ludolph AC
    J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1161. PubMed ID: 12876266
    [No Abstract]   [Full Text] [Related]  

  • 13. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
    Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
    Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAT2 Genotype and Isoniazid Medication in Children.
    Golka K; Selinski S
    EBioMedicine; 2016 Sep; 11():11-12. PubMed ID: 27591833
    [No Abstract]   [Full Text] [Related]  

  • 15. NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis.
    Lee SW; Chung LS; Huang HH; Chuang TY; Liou YH; Wu LS
    Int J Tuberc Lung Dis; 2010 May; 14(5):622-6. PubMed ID: 20392357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tuberculosis: relevance of isoniazid dosage in prevention of liver side effects].
    Negri L; Le Grusse J; Séraissol P; Lavit M; Houin G; Gandia P
    Therapie; 2014; 69(6):509-16. PubMed ID: 25314930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic profile of the arylamine N-acetyltransferase 2 coding gene among individuals from two different regions of Brazil.
    Teixeira RL; Miranda AB; Pacheco AG; Lopes MQ; Fonseca-Costa J; Rabahi MF; Melo HM; Kritski AL; Mello FC; Suffys PN; Santos AR
    Mutat Res; 2007 Nov; 624(1-2):31-40. PubMed ID: 17509624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population.
    Yamada S; Tang M; Richardson K; Halaschek-Wiener J; Chan M; Cook VJ; Fitzgerald JM; Elwood RK; Brooks-Wilson A; Marra F
    Pharmacogenomics; 2009 Sep; 10(9):1433-45. PubMed ID: 19761367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between CYP2E1 polymorphisms and hepatotoxicity due to anti-tuberculosis drugs: a meta-analysis.
    Sheng YJ; Wu G; He HY; Chen W; Zou YS; Li Q; Zhong L; Huang YM; Deng CL
    Infect Genet Evol; 2014 Jun; 24():34-40. PubMed ID: 24607341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    Grant DM; Blum M; Beer M; Meyer UA
    Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.